0082N0 Intrinsic Valuation and Fundamental Analysis - Kanaph Therapeutics Inc - Alpha Spread

K

Watchlist Manager

Watchlist

Price: 10 210 KRW -8.18% Market Closed

Market Cap: ₩129.2B

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value for Kanaph Therapeutics Inc.

Do our valuations actually work? See backtest results .

Fundamental Analysis

What Kanaph Therapeutics Does

Biotechnology Health Care

Kanaph Therapeutics Inc. engages in the research and development of antibody drugs based on human genome based drug development technology. The company is headquartered in Seoul, Seoul. The company went IPO on 2026-03-16. The firm is engaged in the research and development of anticancer drugs and ophthalmic disease treatments based on human genome-based drug discovery technologies. The firm primarily researches and develops bispecific antibodies including immuno-oncology and ophthalmic disease treatments, targeted anticancer antibody-drug conjugate (ADC) new drugs and ADC platform…

Headquarters: Korea KR
IPO date: Mar 16, 2026

Read the full company overview

View Company Overview

Wall St Price Targets

Capital Returns

Buyback Yield

What is Buyback Yield?

Debt Paydown Yield

What is Debt Paydown Yield?

Competitive Landscape

Continue 0082N0 Research

Relative Valuation

Wall St Estimates

Financial Statements

Join 361,000+ value investors using Alpha Spread

Create Free Account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.